Thrombocytopenia and Symmetrical Peripheral Gangrene Associated with Staphylococcal and Streptococcal Bacteremia
Authors: JAMES J. RAHAL
Journal: Annals of Internal Medicine (1968)

Article1 July 1968Thrombocytopenia and Symmetrical Peripheral Gangrene Associated with Staphylococcal and Streptococcal BacteremiaJAMES J. RAHAL JR., M.D., H. EDWARD MACMAHON, M.D., LOUIS WEINSTEIN, PH.D., M.D., F.A.C.P.JAMES J. RAHAL JR., M.D., H. EDWARD MACMAHON, M.D., LOUIS WEINSTEIN, PH.D., M.D., F.A.C.P.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-69-1-35 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThree cases of acute bacteremia due to gram-positive cocci in which thrombocytopenia was accompanied by either symmetrical peripheral gangrene or diffuse purpura were studied. The causal agent was Staphylococcus aureus in two and Streptococcus pyogenes in one. Plasma fibrinogen levels were normal in two patients and depressed in the third. Postmortem examination of the gangrenous fingertips of the patient in the first case (staphylococcal endocarditis) revealed occlusion of arterioles with fibrin thrombi, a dense polymorphonuclear reaction, and no demonstrable bacteria. The second patient had both peripheral gangrene and renal failure associated with streptococcal bacteremia. The renal glomeruli contained isolated capillary fibrin thrombi and blood in the capsular space. The third person developed purpura and hypofibrinogenemia during the course of staphylococcal endocarditis. Evidence of thrombosis was not present during life, but autopsy revealed bleeding into pulmonary alveoli and massive fibrin deposition in diffuse areas of septic infarction.Available experimental evidence indicates that the extracellular toxins of both the staphylococcus and the streptococcus as well as the endotoxin of gram-negative organisms causes platelet damage and aggregation. Staphylococcal alpha toxin also produces marked vasospasm, and staphylocoagulase catalyzes the formation of fibrin from fibrinogen in vitro. The possible relationship of these substances to the clinical phenomena described has been discussed. It is concluded that a continuum exists between thrombocytopenia in severe staphylococcal and streptococcal infection and variable degrees of disseminated intravascular coagulation....References1. MCKAY DG and MARGARETTEN W: Disseminated intravascular coagulation in virus diseases. Arch. Intern. Med. (Chicago) 120: 129, 1967. CrossrefMedlineGoogle Scholar2. SHAFFNER W, MCLEOD AC, and KOENIG MG: Thrombocytopenic Rocky Mountain spotted fever. Arch. Intern. Med. (Chicago) 116: 857, 1965. CrossrefMedlineGoogle Scholar3. CHERNOF D: Hypofibrinogenemia in scrub typhus. Report of a case. New Eng. J. Med. 276: 1195, 1967. CrossrefMedlineGoogle Scholar4. DENNIS LH, EICHELBERGER JW, INMAN MM, and CONRAD ME: Depletion of coagulation factors in drug resistant Plasmodium falciparum malaria. Blood 29: 713, 1967. MedlineGoogle Scholar5. COHEN P and GARDNER FH: Thrombocytopenia as a laboratory sign and complication of gram-negative bacteremic infection. Arch. Intern. Med. (Chicago) 117: 113, 1967. CrossrefGoogle Scholar6. RAPAPORT SI, TATTER D, COEUR-BARRON N, and HJORT PF: Pseudomonas septicemia with intravascular clotting leading to the generalized Shwartzman reaction. New Eng. J. Med. 271: 80, 1964. CrossrefMedlineGoogle Scholar7. HJORT PF and RAPAPORT SI: The Shwartzman reaction: pathogenetic mechanisms and clinical manifestations. Ann. Rev. Med. 16: 135, 1965. CrossrefMedlineGoogle Scholar8. ABILDGAARD CF, CARRIGAN JJ, SEELER RA, SIMONE JV, and SCHULMAN I: Meningococcemia associated with intravascular coagulation. Pediatrics 40: 78, 1967. CrossrefMedlineGoogle Scholar9. MCGEHEE WG, RAPAPORT SI, and HJORT PF: Intravascular coagulation in fulminant meningococcemia. Ann. Intern. Med. 67: 250, 1967. LinkGoogle Scholar10. PEPPER OH: Hematology of subacute Streptococcus viridans endocarditis. JAMA 89: 1377, 1927. CrossrefGoogle Scholar11. WILSON R and HAMBURGER M: Fifteen years' experience with staphylococcus septicemia in a large city hospital. Analysis of fifty-five cases in the Cincinnati General Hospital 1940-1954. Amer. J. Med. 22: 437, 1957. CrossrefMedlineGoogle Scholar12. BLACK PH, SWARTZ MN, SHARP JT, KUNZ LJ, STOKES J, and MCFARLAND RB: Severe streptococcal disease. Observations during an epidemic occurring in southern New England, 1958-1959. New Eng. J. Med. 264: 898, 1961. CrossrefGoogle Scholar13. NYDAHL BC and HALL WH: The treatment of staphylococcal infection with nafcillin with a discussion of staphylococcal nephritis. Ann. Intern. Med. 63: 27, 1965. LinkGoogle Scholar14. ROSNER F and RITZ ND: The defibrination syndrome. Arch. Intern. Med. (Chicago) 117: 17, 1966. CrossrefMedlineGoogle Scholar15 RATNOFF OD and NEBEHEY WG: Multiple coagulative defects in a patient with the Waterhouse-Friderichsen syndrome. Ann. Intern. Med. 56: 627, 1962. LinkGoogle Scholar16. RABINOVICH S, EVANS J, SMITH IM, and JANUARY LE: A long-term view of bacterial endocarditis: 337 cases 1924 to 1963. Ann. Intern. Med. 63: 185, 1965. LinkGoogle Scholar17. HALL WH: Purpura fulminans with group B beta-hemolytic streptococcal endocarditis. Arch. Intern. Med. (Chicago) 116: 594, 1965. CrossrefMedlineGoogle Scholar18. PHILIPS VK: Acute meningococcemia with symmetric peripheral gangrene; report of a case with recovery. Ann. Intern. Med. 48: 864, 1958. LinkGoogle Scholar19. WEINER HA: Gangrene of extremities: recently recognized complication of severe meningococic infection. Arch. Intern. Med. (Chicago) 86: 877, 1950. CrossrefGoogle Scholar20. BETTIGOLE RE: Symmetric peripheral gangrene in pneumococcal sepsis. Ann. Intern. Med. 54: 335, 1961. LinkGoogle Scholar21. MACLENNAN JD: The histotoxic clostridial infections of man. Bact. Rev. 26: 177, 1962. CrossrefMedlineGoogle Scholar22. PAINE TF, NOVICK RP, and HALL WH: Fatal gangrene caused by Streptococcus pyogenes. Arch. Intern. Med. (Chicago) 112: 936, 1963. CrossrefGoogle Scholar23. COLLINS RN and NADEL MS: Gangrene due to the hemolytic streptococcus—a rare but treatable disease. New Eng. J. Med. 272: 578, 1965. CrossrefMedlineGoogle Scholar24. STANLEY MM: Bacillus pyocyaneus infections. Amer. J. Med. 2: 253, 347, 1947. CrossrefMedlineGoogle Scholar25. FORKNER CE, FREI E, EDGCOMB JH, and UTZ JP: Pseudomonas septicemia. Observations on twenty-three cases. Amer. J. Med. 25: 877, 1958. CrossrefMedlineGoogle Scholar26. MELENEY FL: A differential diagnosis between certain types of infectious gangrene of the skin: with particular reference to haemolytic streptococcus gangrene and bacterial synergistic gangrene. Surg. Gynec. Obstet. 56: 847, 1933. Google Scholar27. HJORT PF, RAPAPORT SI, and JORGENSEN L: Purpura fulminans. Report of a case successfully treated with heparin and hydrocortisone. Review of 50 cases from the literature. Scand. J. Haemat. 1: 169, 1964. CrossrefMedlineGoogle Scholar28. LLOYD A, KEMBALL M, and FRASER G: Peripheral gangrene in infancy and childhood. Brit. Med. J. 1: 468, 1967. CrossrefMedlineGoogle Scholar29. LAWS JW, FRED HL, SHARP JT, and RABIN ER: Multiple peripheral gangrene. Arch. Intern. Med. (Chicago) 115: 547, 1965. CrossrefMedlineGoogle Scholar30. GROSS RE: Arterial embolism and thrombosis in infancy. Amer. J. Dis. Child. 70: 61, 1945. Google Scholar31. MARTIN W and SHORE BR: Juvenile gangrene. Ann. Surg. 88: 725, 1928. CrossrefMedlineGoogle Scholar32. DAVIS RB: Electron microscopic changes in blood platelets induced by bacterial lipopolysaccharide. Exp. Molec. Path. 5: 559, 1966. CrossrefMedlineGoogle Scholar33. DESPREZ RM and BRYANT RE: Effects of bacterial endotoxin on rabbit platelets. IV. The divalent ion requirements of endotoxin-induced and immunologically induced platelet injury. J. Exp. Med. 124: 971, 1966. MedlineGoogle Scholar34. REAM VJ, DEYKIN D, GUREWICH V, and WESSLER S: The aggregation of human platelets by bacterial endotoxin. J. Lab. Clin. Med. 66: 245, 1965. MedlineGoogle Scholar35. MCKAY DG, MARGARETTEN W, and CSAVOSSY I: An electron microscopic study of the effects of bacterial endotoxin on the blood-vascular system. Lab. Invest. 15: 1815, 1966. MedlineGoogle Scholar36. COHEN P, BRAUNWALD J, and GARDNER FH: Destruction of canine and rabbit platelets following intravenous administration of carbon particles or endotoxin. J. Lab. Clin. Med. 66: 263, 1965. MedlineGoogle Scholar37. WEST RL, ELOVITZ MJ, and HARDAWAY RM: Blood coagualtion factor activity in experimental endotoxin. Ann. Surg. 163: 567, 1966. CrossrefMedlineGoogle Scholar38. ARTENSTEIN MS, MADOFF MA, and WEINSTEIN L: Studies of the biologic activity of purified staphylococcal alpha toxin. I. The effect of alpha-toxin on cells in tissue culture. Yale J. Biol. Med. 35: 373, 1963. MedlineGoogle Scholar39. MADOFF MA, ARTENSTEIN MS, and WEINSTEIN L: Studies of the biologic activity of purified staphylococcal alpha toxin. II. The effect of alpha-toxin on Ehrlich ascites carcinoma cells. Ibid., p. 382. Google Scholar40. RAHAL JJ, PLAUT ME, ROSEN H, and WEINSTEIN L: Purified staphylococcal alpha toxin: effect on epithelial ion transport. Science 155: 1118, 1967. CrossrefMedlineGoogle Scholar41. MADOFF MA and WEINSTEIN L: Purification of staphylococcal alpha-hemolysin. J. Bact. 83: 914, 1962. CrossrefMedlineGoogle Scholar42. BERNHEIMER AW and SCHWARTZ LL: Effects of staphylococcal and other bacterial toxins on platelets in vitro. J. Path. Bact. 89: 209, 1965. CrossrefMedlineGoogle Scholar43. MANOHAR M, MAHESWARAN SK, FROMMES SP, and LINDORFER RL: Platelet damaging factor, a fifth activity of staphylococcal α toxin. J. Bact. 94: 224, 1967. CrossrefMedlineGoogle Scholar44. SIEGEL I and COHEN S: Action of staphylococcal toxin on human platelets. J. Infect. Dis. 114: 488, 1964. CrossrefMedlineGoogle Scholar45. JELJASZEWICZ J, NIEWIAROWSKI S, POPLAWSKI A, and BLAWAT L: Platelet aggregation by staphylococcal toxins. Thromb. Diath. Haemorrh. 15: 69, 1966. MedlineGoogle Scholar46. NAKAI H and MARGARETTEN W: Effect of staphylococcal toxin on the rabbit kidney. Arch. Path. (Chicago) 76: 38, 1963. MedlineGoogle Scholar47. WURZEL M, BERNHEIMER AW, and SWEIFACH BW: Staphylococcal alpha-toxin-induced contraction of isolated arterial smooth muscle. Amer. J. Physiol. 210: 360, 1966. CrossrefMedlineGoogle Scholar48. GLADSTONE GP and YOSHIDA A: The cytopathic action of purified staphylococcal delta-haemolysin. Brit. J. Exp. Path. 48: 11, 1967. MedlineGoogle Scholar49. TAGER M and DRUMMOND MC: Staphylocoagulase. Ann. N.Y. Acad. Sci. 128: 92, 1965. CrossrefMedlineGoogle Scholar50. JELJASZEWICZ J, NIEWIAROWSKI S, POPLAWSKI A, PROKOPOWICZ J, and WOROWSKI K: Intravascular coagulation and fibrinolysis by staphylocoagulase. Comparison with thrombin. Thromb. Diath. Haemorrh. 13: 171, 1966. Google Scholar51. JELJASZEWICZ J: Staphylococcal coagulase. Postepy Mikrobiol. 2: 171, 1966. Google Scholar52. WEST RL, JENNINGS PB, HARDAWAY RM, and LUNDBERG EA: Effect of heparin on the decrease in blood coagulation factor activity associated with experimental endotoxemia. Ann. Surg. 165: 351, 1967. CrossrefMedlineGoogle Scholar53. SANDERS E: Inhibition of coagulase reaction of pathogenic staphylococci by heparin in vitro. II. Use of sterile, cell-free preparation of coagulase. J. Bact. 86: 1350, 1963. CrossrefMedlineGoogle Scholar54. SOULIER JP and PROU O: Staphylocoagulase and prothrombin. Thromb. Diath. Haemorrh. 20 (suppl.): 254, 1966. Google Scholar55. POWELL DE: Non-suppurative lesions in staphylococcal septicaemia. J. Path. Bact. 82: 141, 1961. CrossrefMedlineGoogle Scholar56. POWELL DE: Staphylococcal septicaemia in a general hospital. Brit. Med. J. 2: 336, 1961. CrossrefMedlineGoogle Scholar57. GILBERT CF: Effects of staphylococcal enterotoxin B on the coagulation mechanism and leukocyte response in beagle dogs—a preliminary study. Thromb. Diath. Haemorrh. 16: 697, 1966. MedlineGoogle Scholar58. BANGHAM AD, STANDISH MM, and WEISSMAN G: The action of steroids and streptolysin S on the permeability of phospholipid structures to cations. J. Molec. Biol. 13: 253, 1965. CrossrefMedlineGoogle Scholar59. BERNHEIMER AW and SCHWARTZ LL: Lysis of bacterial protoplasts and spheroplasts by staphylococcal alpha-toxin and streptolysin S. J. Bact. 89: 1387, 1965. CrossrefMedlineGoogle Scholar60. FAUVE RM, ALOUF JE, DELAUNAY A, and RAYNAUD M: Cytotoxic effects in vitro of highly purified streptolysin O on mouse macrophages cultured in a serum-free medium. J. Bact. 92: 1150, 1966. CrossrefMedlineGoogle Scholar61. LEVIN J and CLUFF LE: Platelets and the Shwartzman phenomenon. J. Exp. Med. 121: 235, 1965. CrossrefMedlineGoogle Scholar62. RODRÍGUEZ-ERDMANN F: Pathogenesis of bilateral cortical necrosis of the kidneys. Hematological observations after the injection of staphylococcal toxin. Med. Pharmacol. Exp. (Basel) 15: 85, 1966. CrossrefMedlineGoogle Scholar63. RODRÍGUEZ-ERDMANN F: Bleeding due to increased intravascular blood coagulation. Hemorrhagic syndromes caused by consumption of blood-clotting factors (consumption-coagulopathies). New Eng. J. Med. 273: 1370, 1965. CrossrefMedlineGoogle Scholar64. MCKAY DG and MULLER-BERGHAUS G: Therapeutic implications of disseminated intravascular coagulation. Amer. J. Cardiol. 20: 392, 1967. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: JAMES J. RAHALJR., M.D.; H. EDWARD MACMAHON, M.D.; LOUIS WEINSTEIN, PH.D., M.D., F.A.C.P.Affiliations: Boston, MassachusettsFrom the Infectious Disease Service of the New England Medical Center Hospitals and the Departments of Medicine, Pediatrics, and Pathology, Tufts University School of Medicine, Boston, Mass.These studies were supported by training grant 5TIAI-276, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.Dr. Rahal was supported in this work by a research fellowship from the Medical Foundation, Inc., Boston, Mass.Requests for reprints should be addressed to James J. Rahal, Jr., M.D., New England Medical Center Hospitals, 171 Harrison Ave., Boston, Mass. 02111. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byPlatelet Kinetics and Laboratory Evaluation of ThrombocytopeniaPeripheral gangrene in an 18-month-old boy with Plasmodium vivax malariaAntigenic Complementarity in the Origins of Autoimmunity: A General Theory Illustrated With a Case Study of Idiopathic Thrombocytopenia PurpuraPurpura Fulminans Due to Staphylococcus aureusSymmetrical Peripheral Gangrene: A New Presentation of an Old DiseaseThe etiology of cutaneous necrotizing vasculitisPercutaneous valvuloplasty to relieve stenosis of a bioprosthetic tricuspid valve in a patient with bacterial endocarditisThrombocytopeniaStreptococcal toxic shockCase 4-1988TREATMENT OF ACUTE RENAL FAILURE, SYMMETRICAL PERIPHERAL GANGRENE, AND SEPTICAEMIA WITH PLASMA EXCHANGE AND EPOPROSTENOLCase 29-1986Acute vascular problems of childrenSymposium on Staphylococcal Septicaemia and Endocarditis. Lund, Sweden, March 17–18, 1983Purpura fulminansFatal streptococcal septicaemia.Thrombocytopenia in Neonatal InfectionNeuere Vaskulitis-SyndromeA Prospective Study on Septicemia: II. Clinical Manifestations and Complications, Results of Antimicrobial Treatment and Report of a Follow-up StudyFulminant gram-negative bacillemia (DF-2) following a dog bite in an asplenic womanA Catastrophic InfectionThe Haematology of Bacterial Infection in Newborn InfantsThrombocytopenia with External Genital GangreneInfective endocarditis—1973Some salient features of staphylococcus aureus endocarditisAutoimmune thrombocytopenic purpura and the compensated thrombocytolytic stateCase 26-1971Generalized Shwartzman Reaction in Man After a Dog Bite Consumption Coagulopathy, Symmetrical Peripheral Gangrene, and Renal Cortical NecrosisBURT R. MEYERS, M.D., SHALOM Z. HIRSCHMAN, M.D., F.A.C.P., WILLIAM SLOAN, M.D.DISSEMINATED INTRAVASCULAR COAGULATIONCase 48-1969 1 July 1968Volume 69, Issue 1Page: 35-43KeywordsAlveoliAutopsyBacteremiaEndocarditisFibrinFibrinogenInfectious diseasesStreptococcus pyogenesThrombosisToxins ePublished: 1 December 2008 Issue Published: 1 July 1968 PDF downloadLoading ...